Literature DB >> 21622628

Metabolism and disposition of isoflavone conjugated metabolites in humans after ingestion of kinako.

Kaori Hosoda1, Takashi Furuta, Kazuo Ishii.   

Abstract

Isoflavone aglycones daidzein (Dein) and genistein (Gein) are present primarily as glucuronides and sulfates in human plasma; however, very little is known about the plasma pharmacokinetics of isoflavone conjugates after soy ingestion. The aim of this study was to investigate metabolism and disposition of the isoflavone conjugated metabolites glucuronide or sulfate or both after ingestion of kinako (baked soybean flour) by 10 volunteers. The quantifications of 16 metabolites in plasma and urine were performed by our previously reported high-performance liquid chromatography-UV-diode-array detector method. Plasma concentrations of total Dein and Gein metabolites reached maximal values of 0.64 ± 0.18 μM at 4.7 ± 2.5 h and 1.58 ± 0.55 μM at 5.4 ± 2.1 h, respectively. The area under the curve from 0 to 48 h demonstrated that daidzein-7-glucuronide-4'-sulfate (D-7G-4'S) (53.3%) was a major metabolite of Dein and that genistein-7-glucuronide-4'-sulfate (G-7G-4'S) (54.0%) and genistein-4',7-diglucuronide (G-4',7-diG) (26.6%) were major metabolites of Gein in plasma. The compositions of isoflavone metabolites in urine and plasma were greatly different. Approximately half of the 48-h urinary excretion of total Dein metabolites consisted of daidzein-7-glucuronide. The total amounts of genistein-7-glucuronide and genistein-4'-glucuronide were half the total amount of the urinary Gein metabolites. Excretion into urine of D-7G-4'S and G-7G-4'S accounted for only 16% each of the total Dein and Gein metabolites, respectively. The plasma and urine profiles of 16 metabolites of Dein and Gein demonstrate the involvement of desulfation and deglucuronidation of the conjugated metabolites D-7G-4'S, G-7G-4'S, and G-4',7-diG in the process of renal excretion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622628     DOI: 10.1124/dmd.111.038281

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

Review 1.  Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Authors:  S Hüser; S Guth; H G Joost; S T Soukup; J Köhrle; L Kreienbrock; P Diel; D W Lachenmeier; G Eisenbrand; G Vollmer; U Nöthlings; D Marko; A Mally; T Grune; L Lehmann; P Steinberg; S E Kulling
Journal:  Arch Toxicol       Date:  2018-08-21       Impact factor: 5.153

2.  In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.

Authors:  Rungnapa Boonpawa; Albertus Spenkelink; Ans Punt; Ivonne M C M Rietjens
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

3.  Estrogenic in vitro evaluation of zearalenone and its phase I and II metabolites in combination with soy isoflavones.

Authors:  Dino Grgic; Andrea Betschler; Rebeka Früholz; Barbara Novak; Elisabeth Varga; Doris Marko
Journal:  Arch Toxicol       Date:  2022-08-20       Impact factor: 6.168

4.  Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops.

Authors:  LeeCole Legette; Chanida Karnpracha; Ralph L Reed; Jaewoo Choi; Gerd Bobe; J Mark Christensen; Rosita Rodriguez-Proteau; Jonathan Q Purnell; Jan F Stevens
Journal:  Mol Nutr Food Res       Date:  2013-08-27       Impact factor: 5.914

Review 5.  Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.

Authors:  Zhen Yang; Kaustubh Kulkarni; Wei Zhu; Ming Hu
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

6.  Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract Obesity.

Authors:  Veronica Valli; Katharina Heilmann; Francesca Danesi; Alessandra Bordoni; Clarissa Gerhäuser
Journal:  Oxid Med Cell Longev       Date:  2018-02-07       Impact factor: 6.543

7.  Identification of equol-7-glucuronide-4'-sulfate, monoglucuronides and monosulfates in human plasma of 2 equol producers after administration of kinako by LC-ESI-MS.

Authors:  Aki Obara; Mizuki Kinoshita; Kaori Hosoda; Akitomo Yokokawa; Hiromi Shibasaki; Kazuo Ishii
Journal:  Pharmacol Res Perspect       Date:  2019-05-09

Review 8.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.

Authors:  Daniele Del Rio; Ana Rodriguez-Mateos; Jeremy P E Spencer; Massimiliano Tognolini; Gina Borges; Alan Crozier
Journal:  Antioxid Redox Signal       Date:  2012-08-27       Impact factor: 8.401

9.  Formation of phosphoglycosides in Caenorhabditis elegans: a novel biotransformation pathway.

Authors:  Sebastian T Soukup; Britta Spanier; Gregor Grünz; Diana Bunzel; Hannelore Daniel; Sabine E Kulling
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  A Comprehensive Screening and Identification of Genistin Metabolites in Rats Based on Multiple Metabolite Templates Combined with UHPLC-HRMS Analysis.

Authors:  Yaoyue Liang; Wenjing Zhao; Chenxiao Wang; Zijian Wang; Zhibin Wang; Jiayu Zhang
Journal:  Molecules       Date:  2018-07-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.